Subject matter expert in the interface between biology and engineered systems. As a member of the UK management team, my role combines business development, operations, and technical leadership.

I served as a technical subject matter expert in biomedical engineering and drug delivery, focusing on developing strategic partnerships and fostering business growth.

As a member of the management team, I contributed to company growth through active participation in business development, recruitment, mentorship, and enhancing our technical capabilities in areas such as CCIT and design for 5 9's reliability. During this time I advanced designs from concept to pilot production, focusing on new product development. A key achievement was leading the development of the ArQ Bios Autoinjector Platform, encompassing design, manufacturing, and testing of the device and its primary packaging. I also developed several innovative container closure technologies for oxygen-sensitive and oil-based formulations. (ISO 13485, ISO 14971, ISO 11608, ISO 10993, ISO 11040, FDA 21 CFR part 820).

I was responsible for designing and developing Oval's ArQ® - Bios high viscosity/large volume autoinjector platform.

In my capacity as a senior engineer, I oversaw the engineering project management for hands-on design, prototyping, and development across diverse fields, including medical devices, drug delivery systems, embolic technologies, biointerface interactions (implanted structures), MRI systems, diagnostic devices, upstream and downstream bioprocessing, membranes, filtration and separation technologies, and API drying technologies.

I contributed to engineering teams, providing expertise in mechanical and biomedical engineering. My work primarily focused on projects involving drug delivery, emergency medical equipment, and biopharmaceutical processing.

My research in biomedical engineering focused on the design We have developed a method for constructing self-assembling nanopatterned scaffolds. These scaffolds utilize microscopic, environmentally responsive hydrogel hinges to facilitate folding, enabling the capture of stem cells from solution. The nanopatterned inner surfaces of these structures are designed to differentiate the stem cells into liver organoids, which can then be used in lab-on-a-chip and patient-on-a-chip applications for targeted drug development.Key topics: Stem cells, smart hydrogels, tissue scaffolds, regenerative medicine, biointerfaces, nanoimprint lithography (NIL), microfabrication, and nanotechnology.Outputs:- Created a novel process for high-throughput 2.5D nanopatterning of biocompatible materials.- Developed smart hydrogel bilayer films and a patterning process to create hydrogel micro-actuators.- Designed novel self-assembling microcontainers (bioMEMS) powered by smart hydrogel actuators.

Provided support and logistical management for local IMechE events, outreach activities, and membership support for the engineering community in southwest Scotland.

Developed conceptual designs for a spectroscopic blood glucose monitor and several wearable peripheral devices were developed, leveraging preliminary product design specifications and human factors research. These designs facilitated the securing of seed funding.

Performed fatigue and stress analysis of composite orthopedic cement materials via mechanical testing and finite element analysis (FEA).Developed models of fatigue fracture propagation at the cement/implant interface following hip arthroplasty, revealing a strong correlation between fatigue life and pre-surgical cement preparation technique.Received the Scottish Association for Metals award for best materials-related final-year project (2011).

A comparative analysis of fracture mechanics modeling methods applicable to metallic and ceramic materials was performed. Guidelines for model selection were developed, considering material properties and geometric characteristics.